Spanish biotechnology-dedicated venture capital firm Ysios Capital has raised €155m for its third fund, Ysios BioFund III, which has a final target of €200m.
Deal is the first from the GP's Genesis Growth Equity Fund I, which is targeting €40m
VC fund has made its first investment in DSP Neural, which raised €5m in a series-A round
Acquisition is expected to allow Arkessa to strengthen its presence in the Netherlands
Fondo Axon Innovation Growth IV acquires minority stakes in technology businesses with high-growth potential